Stevanato Group Shareholders Approve All Resolutions at 2026 Annual Meeting, Including Dividend and Board Appointments
核心洞察
Stevanato Group (搜索) shareholders approved all resolutions at the Ordinary and Extraordinary Meeting held virtually on May 26, 2026, including the 2025 annual financial statements.
A dividend of EUR 0.054 per outstanding Class A and ordinary share was approved, net of treasury shares.
An eleven-member Board of Directors was appointed, with Peter Soelkner joining as the sole new member alongside ten returning directors.
Stevanato Group (搜索) S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, announced that all resolutions proposed to shareholders at its Ordinary and Extraordinary Meeting of Shareholders, held virtually on May 26, 2026, have passed.
The approved resolutions span financial, governance, and structural matters that position the company for its next phase of operations.
Financial Approvals and Dividend Distribution
Shareholders approved the annual financial statements for the financial year ended December 31, 2025, along with the allocation of annual net profits. A key outcome was the approval of a dividend distribution in the amount of EUR 0.054 for each outstanding Class A and ordinary share of the Company, net of treasury shares.
Board of Directors Composition
An eleven-member Board of Directors was appointed, comprising ten returning members — Franco Stevanato, Sergio Stevanato, Madhavan Balachandran, William Federici, Karen Flynn, Sue Jean Lin, Elisabetta Magistretti, Donald Eugene Morel Jr., Luciano Santel, and Alvise Spinazzi — together with Peter Soelkner, who is newly appointed to the board.
Auditor Appointment and Compensation Matters
Shareholders approved the compensation of the members of the Board of Directors and of the members of the Audit Committee. Additionally, PricewaterhouseCoopers (搜索) S.p.A. was appointed as external auditor for the auditing of the Company's financial statements and consolidated financial statements, as well as for the performance of further tasks and activities in compliance with Italian and U.S. laws and regulations, covering the financial years ending December 31, 2026, December 31, 2027, and December 31, 2028.
Treasury Share Authorization
Due to the expiration of existing authorizations, shareholders granted the Board of Directors a new authorization for the purchase and disposal of ordinary and Class A treasury shares, for the period and purposes indicated in the explanatory report prepared by the Board.
By-law Amendments
In the extraordinary session, shareholders approved amendments to Articles 7.6, 16 and 23 of the Company's By-laws. These amendments aim to facilitate the exercise of corporate rights by beneficial shareholders of ordinary shares, introduce the possibility for the outgoing Board of Directors to submit a slate of candidates for the appointment of the new Board of Directors, and grant the Board of Directors greater flexibility in the appointment of members of the Audit Committee.
Further information regarding the Shareholders' Meeting, including the full text of the meeting notice, explanatory report, and other materials, is available on the investors' section of Stevanato Group (搜索)'s corporate website.